Modified release paracetamol overdose: a prospective observational study (ATOM-3)
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Modified-release (MR) paracetamol is available in many countries as 665 mg tablets of which 69% is MR and 31% is immediate release. There are concerns that MR paracetamol overdose has higher rates of liver injury despite standard treatment algorithms. The objective of this study was to describe the clinical characteristics and outcomes of acute MR paracetamol overdose. METHODS: Prospective observational study, recruiting patients from January 2013 to June 2017, from five clinical toxicology units and calls to two Poisons Information Centres in Australia. Included were patients >14 years who ingested ≥10 g or 200 mg/kg (whichever is less) of MR paracetamol. Data collected included demographics, ingestion history, pathology results, treatments, and outcomes including hepatotoxicity (ALT >1000 U/L). RESULTS: In total, 116 patients were recruited, 85(73%) were female. The median dose ingested was 32 g (IQR: 20-49 g) and median time to presentation was 3 h (IQR: 2-9 h). 78(67%) had an initial paracetamol concentration above the nomogram line (150 mg/L at 4 h). A further 12(10%) crossed the nomogram after repeat paracetamol measurements, of which five crossed after two non-toxic levels 4 h apart. Six had a double paracetamol peak, in three occurring >24 h post-ingestion. 113(97%) received acetylcysteine of which 67 received prolonged treatment beyond the standard 21 h. This was because of an elevated paracetamol concentration at the completion of acetylcysteine in 39 (median paracetamol concentration 25 mg/L, IQR: 16-62 mg/L). 21 (18%) developed hepatotoxicity, including six treated within 8 h of ingestion. Activated charcoal and double doses of acetylcysteine did not significantly decrease the risk of hepatotoxicity. CONCLUSIONS: Drug regulatory authorities are considering restrictions on MR paracetamol preparations. Following an acute MR paracetamol overdose, this study found that many patients had a persistently elevated paracetamol concentrations, many required prolonged treatment and some developed liver injury despite early acetylcysteine treatment. Furthermore, activated charcoal and increased acetylcysteine did not appear to significantly alter the risk of liver injury. Hence, research into better treatment strategies is required. TRIAL REGISTRATION: Australian Toxicology Monitoring (ATOM) Study - Australian Paracetamol Project: ACTRN12612001240831 (ANZCTR) Date of registration: 23/11/2012.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Large overdoses and those involving modified-release paracetamol are high-risk and can be targeted through legislative change.”
From Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures, and estimates of burden of disease (2023) · cites this paper as [54]
In the citing paper
“There is a higher risk of hepatotoxicity even with early treatment, likely due to the generally higher doses and a mismatch between the timing of acetylcysteine and high paracetamol concentrations.”
From Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures, and estimates of burden of disease (2023) · cites this paper as [54]
In the citing paper
“Overdose with MR paracetamol has been associated with very prolonged absorption and multiple peaks [54] in paracetamol concentrations may occur after overdose and patients often require prolonged treatment due to continuously elevated concentrations [51,54,55].”
From Paracetamol (acetaminophen) overdose and hepatotoxicity: mechanism, treatment, prevention measures, and estimates of burden of disease (2023) · cites this paper as [54]
Citations
Cites
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
Mehta, R. L., Kellum, J. A., Shah, S. V., Molitoris, B. A., Ronco, C., Warnock, D. G., Levin, A., & the Acute Kidney Injury Network (2007) · Critical Care · doi:10.1186/cc5713 · Cited by 7,048 · cited 1×
“0), severe acute kidney injury (AKIN classification stage 3) [8] and hepatic encephalopathy.”
BackgroundEfficacy of Oral N-Acetylcysteine in the Treatment of Acetaminophen Overdose
Smilkstein, M. J., Knapp, G. L., Kulig, K. W., & Rumack, B. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812153192401 · Cited by 1,102 · cited 1×
“Ratios were not done after 16 h because the Prescott nomogram is validated as predicting risk to 15–16 h [5,6].”
Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning.
Prescott, L. F., Illingworth, R. N., Critchley, J. A., Stewart, M. J., Adam, R. D., & Proudfoot, A. T. (1979) · BMJ · doi:10.1136/bmj.2.6198.1097 · Cited by 667
Intravenous N-acetylcysteine: still the treatment of choice for paracetamol poisoning.
Prescott, L. F., Illingworth, R. N., Critchley, J. A., & Proudfoot, A. T. (1980) · BMJ · doi:10.1136/bmj.280.6206.46-b · Cited by 626
Antoine, D. J., Dear, J. W., Lewis, P. S., Platt, V., Coyle, J., Masson, M., Thanacoody, R. H., Gray, A. J., Webb, D. J., Moggs, J. G., et al. (2013) · Hepatology · doi:10.1002/hep.26294 · Cited by 427 · cited 1×
“Others considered included ALT >50U/L (the typical upper limit of normal and Australian indication for continuing acetylcysteine therapy after completion of the initial regimen) [4] and ALT >150U/L (the UK indication for continuing acetylcysteine therapy after completion of the initial regimen) [7].”
BackgroundActivated charcoal for acute overdose: a reappraisal
Juurlink, D. N. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12793 · Cited by 128 · cited 1×
“As in the awake and alert patient charcoal is a low risk intervention and further studies are required to determine its efficacy in MR paracetamol ingestion [15,16].”
BackgroundChiew, A. L., Isbister, G. K., Kirby, K. A., Page, C. B., Chan, B. S. H., & Buckley, N. A. (2017) · Clinical Toxicology · doi:10.1080/15563650.2017.1334915 · Cited by 107 · cited 2×
“In a study of massive ( 40 g) IR paracetamol ingestion where a similar proportion (25%) received activated charcoal; those who received activated charcoal had a significantly lower paracetamol ratio with a decrease in paracetamol ratio of 45% [12].”
BackgroundResultSelf-citationChiew, A. L., Fountain, J. S., Graudins, A., Isbister, G. K., Reith, D. M., & Buckley, N. A. (2015) · The Medical Journal of Australia · doi:10.5694/mja15.00614 · Cited by 58 · cited 3×
“concentration that is double the standard nomogram line [4].”
BackgroundSelf-citationIndications for single-dose activated charcoal administration in acute overdose
Isbister, G. K., & Kumar, V. V. P. (2011) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e328348bf59 · Cited by 46 · cited 1×
“As in the awake and alert patient charcoal is a low risk intervention and further studies are required to determine its efficacy in MR paracetamol ingestion [15,16].”
BackgroundSelf-citationAnalgesic efficacy of sustained release paracetamol in patients with osteoarthritis of the knee
Bacon, T. H., Hole, J., North, M., & Burnett, I. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01603.x · Cited by 33 · cited 1×
“The sole advantage is a dosing regimen that is three rather than four times a day [9,10].”
Background
Research works printed but not linked: 1
- Coulthard P, 2001, Br Dent J, 191, 319, 10.1038/sj.bdj.4801174 · doi:10.1038/sj.bdj.4801174
Cited by
Chidiac, A. S., Buckley, N. A., Noghrehchi, F., & Cairns, R. (2023) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2023.2223959 · Cited by 215
“often require prolonged treatment due to continuously elevated concentrations [51,54,55].”
BackgroundSelf-citationUpdated guidelines for the management of paracetamol poisoning in Australia and New Zealand
Chiew, A. L., Reith, D., Pomerleau, A., Wong, A., Isoardi, K. Z., Soderstrom, J., & Buckley, N. A. (2020) · Medical Journal of Australia · doi:10.5694/mja2.50428 · Cited by 145
Self-citationParacetamol poisoning‐related hospital admissions and deaths in Australia, 2004–2017
Cairns, R., Brown, J. A., Wylie, C. E., Dawson, A. H., Isbister, G. K., & Buckley, N. A. (2019) · Medical Journal of Australia · doi:10.5694/mja2.50296 · Cited by 84
Self-citationHoegberg, L. C. G., Shepherd, G., Wood, D. M., Johnson, J., Hoffman, R. S., Caravati, E. M., Chan, W. L., Smith, S. W., Olson, K. R., & Gosselin, S. (2021) · Clinical Toxicology · doi:10.1080/15563650.2021.1961144 · Cited by 82
Chiew, A. L., & Buckley, N. A. (2021) · Critical Care Clinics · doi:10.1016/j.ccc.2021.03.005 · Cited by 55
Self-citation
Metadata
- Authors
- Chiew, A. L., Isbister, G. K., Page, C. B., Kirby, K. A., Chan, B. S. H., & Buckley, N. A.
- Affiliations
- The University of Sydney (AU)
- Children's Hospital at Westmead (AU)
- Princess Alexandra Hospital (AU)
- Corresponding author
- Chiew, Angela L.
- ORCID
- Venue
- Clinical Toxicology
- Publisher
- Informa UK Limited
- Published
- 2018-02-16
- Volume
- 56
- Issue
- 9
- Pages
- 810-819
- ISSN
- 0009-9309 (ISSN-L)
- 1556-3650
- 1556-9519
- OpenAlex
- W2791605190
- Cited by
- 30
- References
- 15
- Citations by year
- 2026: 5 · 2025: 4 · 2024: 3 · 2023: 4 · 2022: 4 · 2021: 3 · 2020: 1 · 2019: 5 · 2018: 1
- FWCI
- 3.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Toxicology (publishedVersion)
- PubMed (publishedVersion)
- NOVA (University of Newcastle Australia) (submittedVersion)
- Topics
- Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Paraquat toxicity studies and treatments
- Keywords
- acetaminophen overdose, hepatotoxicity, N-acetylcysteine, activated carbon, drug regulation, poison control centers
- MeSH terms
- Acetaminophen, Adult, Australia, Charcoal, Delayed-Action Preparations, Dose-Response Relationship, Drug, Female, Humans, Male, Middle Aged, Prospective Studies, Retrospective Studies, Analgesics, Non-Narcotic, Young Adult, Chemical and Drug Induced Liver Injury, Drug Overdose
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Modified release paracetamol overdose: a prospective observational study (ATOM-3). https://app.cochat.ai/papers/10.1080/15563650.2018.1439950
- The paper
- Chiew, A. L., Isbister, G. K., Page, C. B., Kirby, K. A., Chan, B. S. H., & Buckley, N. A. (2018). Modified release paracetamol overdose: a prospective observational study (ATOM-3). Clinical Toxicology. https://doi.org/10.1080/15563650.2018.1439950
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.